Phase 2B/3 Double-blinded Placebo-controlled

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

860

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

August 22, 2019

Study Completion Date

August 22, 2019

Conditions
Chlamydia Trachomatis Infection
Interventions
DRUG

EVO100

5 g dose applied up to 1 hour prior to coitus

DRUG

Placebo

5 g dose applied up to 1 hour prior to coitus

Trial Locations (50)

19107

Planned Parenthood Southeastern Pennsylvania, Philadelphia

23502

The Group for Women, Norfolk

27612

Wake Research Associates, LLC, Raleigh

28144

PMG Research of Salisbury, Salisbury

28401

PMG Research, Inc. - Wilmington Health, Wilmington

29169

Invocare Clinical Research Center, West Columbia

30046

Renew Health Clinical Research, LLC, Lawrenceville

31324

Meridian Clinical Research, Richmond Hill

31901

Columbus Regional Research Institute - IACT Health, Columbus

33014

Panax Clinical Research, Miami Lakes

33016

Global Health Research Center, Miami Lakes

33135

South Florida Research Center, Inc., Miami

33319

Precision Clinical Research, Lauderdale Lakes

33409

Comprehensive Clinical Trials, LLC, West Palm Beach

34239

Physician Care Clinical Research LLC, Sarasota

36608

Coastal Clinical Research, Inc., Mobile

Mobile OB-GYN, PC, Mobile

37920

University of Tennessee Medical Center, Knoxville

38120

Adams Patterson OB/GYN, Medical Research Center of Memphis, Memphis

39213

University of MS Medical Center, Jackson

39531

MedPharmics, LLD, Biloxi

41073

University of Cincinnati Physicians, Cincinnati

48602

Valley OB-GYN, Saginaw

60612

John H. Stroger Jr. Hospital of Cook County, Chicago

70124

DelRicht Research, New Orleans

71301

DM Clinical Research, Alexandria

75093

North Texas Family Medicine, Plano

75204

CityDoc Urgent Care, Dallas

77021

Research Network America, Houston

77058

Centex Studios, Inc., Houston

77061

Discovery MM Services, Inc., Houston

77074

S.E.Tx. Family Planning and Cancer Screening (SOGA), Houston

77081

Texas Center for Drug Development, Inc., Houston

77701

Gadolin Research, Beaumont

78212

Neere Bhatia, MD OB/GYN, San Antonio

78735

Premier Family Physicians, Austin

80202

AFC Urgent Care Denver, Denver

83687

ASR, LLC, Nampa

85015

MedPharmics, LLC, Phoenix

85032

Precision Trials AZ, LLC, Phoenix

85745

Eclipse Clinical Research, Tucson

87109

Bosque Women's Care, Albuquerque

89106

Nevada Obstetrical Charity Clinic, Las Vegas

90255

United Clinical Research, Huntington Park

91007

California Center for Clinical Research, Arcadia

91303

Hope Clinical Research, Canoga Park

92108

Medical Center for Clinical Research - Wake Research, San Diego

94102

Optimus Medical Group, Inc., San Francisco

06511

Planned Parenthood of Southern New England, New Haven

15213-3180

Magee Womens Hospital of UPMC, Pittsburgh

Sponsors
All Listed Sponsors
collaborator

Clinical Research Management, Inc.

INDUSTRY

lead

Evofem Inc.

INDUSTRY

NCT03107377 - Phase 2B/3 Double-blinded Placebo-controlled | Biotech Hunter | Biotech Hunter